体外反搏与心功能保护-课件,幻灯,PPT.ppt
《体外反搏与心功能保护-课件,幻灯,PPT.ppt》由会员分享,可在线阅读,更多相关《体外反搏与心功能保护-课件,幻灯,PPT.ppt(40页珍藏版)》请在三一文库上搜索。
1、体外反搏与心功能保护,伍贵富 中山大学附属第一医院心内科 卫生部辅助循环重点实验室 2009.8.22 大连,Enhanced External Counterpulsation(EECP) A Non-invasive Therapy for Heart Failure,心力衰竭治疗存在的问题,社会老龄化,心肌梗塞死亡率下降,但心力衰竭患者增加,健康保障系统不堪重负 目前缺乏治疗心力衰竭的有效手段 心衰死亡率居高不下 (53,000人/年 2001年,USA) 严格定义心力衰竭不易,因其不仅仅是一个单器官病变,而是一个全身性的临床综合征 心力衰竭的治疗不仅仅局限于心功能改善,还需要强调系统性
2、的病理生理机制的干预,心力衰竭的非药物治疗,起搏器(Pacemaker) 植入式心脏除颤器(Implantable cardioverter defibrilator) 心室辅助装置/人工心脏(Ventricular assist device / Artifical heart) 超滤(Utrafiltration) 心室再同步化(Cardiac Resynchronization therapy) 体外反搏(EECP),体内反搏 (IABP),体外反搏 (EECP),辅助衰竭的心脏:从内反搏到外反搏,1962年,USA 液压水囊式体外反搏 非序贯式加压 笨重,体积大 未能推广,1972年,
3、 中国中山大学 序贯式气囊加压体外反搏 重量轻,体积小 安全、有效、无创伤 在中国及全球推广,源自中国的体外反搏(EECP)疗法 获得国际主流媒体的关注和正面报道,中国体外反搏技术的国际影响,推广应用20个国家和地区,体外反搏装置系统工作原理,D/S比值1.2,执行机构,电池阀(开/关),主机系统,体外反搏的作用原理,血流动力学效应,舒张期主动脉根部血流增加,增加CO,增加静脉回心血流,增加心室舒张期充盈,收缩期,舒张期,降低收缩期阻力负荷,增加冠脉血流,Michaels AD, et al. Circulation 2002; 106: 1237-42.,Doppler Flow Veloc
4、ities obtained with FloWire in the LAD,增加冠脉血流,Increase 150%,(N=8),Intracoronary Peak Diastolic Doppler Flow Velocity,Baseline,EECP,Katz WE, et al. J Am Coll Cardiol 1998;31Suppl(2):85A(825-31),EECP 1:1 Mode,IABP 1:1 Mode,Scanning Electron Micrographs,Scale,100 m,(amplification x500),The luminal surf
5、ace was covered with many adherent cells. The endothelial cells were in disarray.,Less cellular adherence Endothelial cells align parallel to direction of blood flow,体外反搏治疗修复损害的血管内膜,Circulation 2007;116:526-534),体外反搏改善内皮依赖的血管舒张能力,70,60,50,40,30,20,10,0,Shear Stress (dynes/cm2),Baseline,During EECP,p
6、0.001,Circulation 2007;116(5):526-536,Shear Stress ,Am J Cardil 2006;98:28-30,Baseline,1hr,12hr,24hr,36hr,1-mo after,3-mo after,% increase of NOx levels over baseline,Nitric Oxide ,*,* p=0.014; p0.0001; p=0.002 vs baseline,During EECP,0,50,100,150,200,Control,CHOL,CHOL +EECP,eNOS protein level (% of
7、 control),*,*,* p 0.05 vs Control *p 0.05 vs CHOL,TCT 2006, Oct 22-27, Washington DC,eNOs ,Circulation 2007;116(5):526-536,*,NO crosses intimal to Smooth Muscular Cells,Smooth Muscle cell relaxation,体外反搏改善血流介导的血管舒张能力,体外反搏治疗后心肌血流灌注明显改善,Am J Cardiol. 1992;70:859-862. and J Crit Illness 2000;15(11):629
8、-36,Exercise (Bruce Protocol) Pre- and Post EECP exercise to the same duration 67% showed complete resolution 11% with partial resolution and 22% no change N=18 pts,Angiogenesis / Collateral Circulation,0.03530.0111,0.00360.0028,p0.01,Area stained with anti-VEGF antibody in infarcted regions (mm2/10
9、2),Control (N=6),EECP (N=6),Vascular Endothelial Growth Factor ,Am J of Physiol Heart Circ Physiol 290:H248-H254,2006,Am J of Physiol Heart Circ Physiol 290:H248-H254,2006,Experimental AMI dog model,Control,EECP,Endothelial Cell Growth ,60 50 40 30 20 10 0,Area strained brown (m2/mm2),p0.05,5,6671,8
10、94,1,7101,497,EECP,Control,Area of new capillaries (m2/mm2 sample field),647531,6,5922,785,p0.05,Smooth Muscle Cell Growth ,X1,000,Cardiology 2008;110:160-166,体外反搏后冠心病心绞痛患者 循环内皮祖细胞增加,改善神经体液因子,26.6,18.8,15.6,Increase (%),HGF,bFGF,VEGF,Circulation 2001;104(17) Suppl II:444(2109),Change in Angiogenic F
11、actors,Eur Heart J 2001;22(16):1451-58,ANP and BNP,Blood Pressure / Myocardial Oxygen Consumption,JACC doi:10.1016/j.jacc.2006.04.094,N=20 patients with refractory angina,Tension-Time-Index ,Baseline,EECP,Units x 102,23 5.1,19 3.9,p0.001,0,10,20,30,40,50,60,Baseline,EECP,56 16,36 13,Dynes-sec-cm2 x
12、102,p0.001,Wasted LV Energy ,Wasted LV pressure energy = 2.09 X tp * (Ps Pi) LV Workload = Tension Time Index = area under systolic wave,Nat Clin Pract Cardiovasc Med 2006;3(11):623-32,国际体外反搏病人注册研究 International EECP Patient Registries (IEPR),美国 Pittsburgh大学组织完成,随访体外反搏治疗后3年 IEPR-1: n=5,056 Jan 1998
13、to July 2001 from 119 US and 21 International sites IEPR-2: n=2,917 consecutive patients from Jan 2002 to Oct 2004 from 95 US sites with 2-year follow-up. Entry criteria: patient gave consent and underwent at least 1 hr of EECP treatment.,Baseline characteristics of Patients in the IEPR,Nat Clin Pra
14、ct Cardiovasc Med 2006;3(11):623-32,Distribution of Canadian Cardiovascular Society Class,% in each CCS Class,Mean # of angina episodes/week 10 14,86% in Class III/IV,0,10,20,30,40,50,60,I,II,III,IV,CAD Patients with History of CHF,Effects of EECP on CCS Anginal Class,Without CHF (N=1,400),Cardiolog
15、y 2001;96:78-94,Data from IEPR,% of Patients in Each CCS Class,Events occurring during the 6-month following EECP,2-year follow-up for Patients with LVD (EF 35%),Am J Cardiol 2006; 97(1):17-20,0,10,20,30,40,50,60,70,% of patients,None,I,II,III,IV,p0.001,77% of patients improved 1 angina class, 8% ha
16、d no angina post treatment (p0.001 baseline vs post-EECP) 55% of patients had sustained improvement in angina class at 2-year follow-up 2-year survival rate was 83%,Canadian Cardiovascular Society Angina Class,93% in Class III/IV pre-EECP,PEECH Trial Prospective Evaluation of EECP in Congestive Hear
17、t Failure,N=187 patients randomized to: EECP therapy plus optimal medical therapy Optimal medical therapy alone 29 centers participating including Cleveland Clinic, Scripps Clinic, Thomas Jefferson and UCSD Co-Primary endpoints at six months following treatment (90% Power) Exercise Tolerance: % of p
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 体外 功能 保护 课件 幻灯 PPT
链接地址:https://www.31doc.com/p-2787819.html